order
investig
abil
oil
adjuv
vaccin
contain
bovin
coronaviru
antigen
enhanc
lactogen
immun
calf
pregnant
cow
heifer
vaccin
viru
neutralis
antibodi
level
determin
serum
colostrum
milk
preexist
antibodi
titr
result
natur
infect
serum
anim
found
increas
result
singl
shot
vaccin
carri
week
calv
similar
increas
titr
durat
antibodi
milk
colostrum
pass
calv
overal
respons
observ
highli
depend
adequ
antigen
payload
incorpor
within
singl
dose
vaccin
abnorm
local
system
reaction
observ
result
vaccin
hope
approach
lead
product
superior
commerci
vaccin
protect
neonat
calv
enter
coronaviru
infect
neonat
diarrhoea
complex
diseas
associ
number
infecti
agent
occur
either
singli
combin
calv
econom
loss
suer
result
mortal
reach
also
veterinari
cost
decreas
product
survivor
viral
agent
commonli
associ
syndrom
rotaviru
coronaviru
shown
primari
pathogen
calv
although
syndrom
overtli
associ
young
anim
subclin
infect
also
common
adult
may
therefor
act
reservoir
reinfect
passiv
immun
enter
viral
infect
depend
upon
continu
presenc
protect
level
antibodi
gut
lumen
achiev
allow
neonat
ingest
colostrum
milk
contain
antibodi
dam
lactogen
immun
although
adult
cattl
seroposit
rotaviru
coronaviru
antibodi
transit
colostrum
milk
product
dramat
declin
antibodi
titr
partial
explain
high
incid
infect
calv
older
day
success
rotaviru
vaccin
aim
increas
titr
durat
antibodi
colostrum
milk
develop
howev
similar
success
report
vaccin
target
bovin
coronaviru
paper
report
abil
new
singl
dose
vaccin
increas
level
durat
coronaviru
neutralis
antibodi
serum
milk
vaccin
cattl
bovin
coronaviru
grown
mammalian
cell
cultur
antigen
product
cell
cultur
supernat
harvest
low
speed
centrifug
viru
inactiv
treatment
binari
ethyleneimin
h
final
viru
concentr
use
hollow
system
molecular
weight
cuto
bovin
coronaviru
antigen
level
determin
quantit
elisa
immulon
removawel
strip
dynex
technolog
coat
optim
concentr
previous
determin
titrat
sheep
polyclon
antibovin
coronaviru
antibodi
dilut
coat
buffer
ph
incub
h
well
block
use
pb
contain
bovin
serum
albumin
tween
min
ambient
temperatur
ml
pb
contain
tween
ad
well
follow
ml
sampl
standard
control
incub
h
shaker
incub
well
wash
three
time
use
pb
contain
tween
ml
optim
dilut
mous
monoclon
antibodi
viru
haemagglutinin
ad
well
follow
incub
h
shake
wash
ml
optim
concentr
horseradish
peroxidas
conjug
goat
antimous
igg
antibodi
nordic
immunolog
ad
well
incub
shake
h
wash
bound
conjug
visualis
use
ophenylenediamin
dihydrochlorid
sigma
chromagen
stop
reaction
use
sulphur
acid
optic
densiti
nm
proport
amount
bovin
coronaviru
antigen
sampl
full
quantit
rang
antigen
unit
per
ml
achiev
includ
set
six
standard
assay
vaccin
compris
rotaviru
e
coli
antigen
rotavec
schere
plough
anim
health
plu
inactiv
bovin
coronaviru
antigen
adjuv
use
miner
oil
base
adjuv
aqueou
oil
phase
prepar
separ
combin
prior
use
silverson
homogenis
twelv
maiden
heifer
mix
breed
previous
treat
vaccin
contain
coronaviru
hous
indoor
bed
straw
although
access
given
grass
paddock
exercis
anim
fed
hay
silag
standard
cattl
ration
quinn
baltinglass
water
avail
ad
libitum
health
anim
monitor
daili
observ
throughout
studi
anim
bled
day
prior
vaccin
serum
prepar
coronaviru
antibodi
titr
determin
anim
rank
descend
antibodi
titr
alloc
four
group
three
anim
base
random
assign
one
anim
third
rank
anim
group
immunis
ml
appropri
vaccin
group
vaccin
contain
vaccin
anim
receiv
singl
ml
inject
intramuscularli
neck
anim
bled
vaccin
day
post
vaccin
heifer
group
also
bled
day
post
vaccin
blood
sampl
store
h
allow
clot
occur
serum
separ
centrifug
store
prior
test
bovin
coronaviru
bcov
antibodi
viru
neutralis
haemagglutin
inhibit
carri
four
farm
two
studi
b
beef
suckler
herd
two
studi
c
dairi
herd
doubl
blind
trial
design
use
thirti
cow
farm
pair
accord
expect
calv
date
randomli
alloc
either
vaccin
placebo
treatment
group
cow
per
group
anim
includ
studi
basi
expect
calv
date
fell
week
later
day
vaccin
anim
exclud
unhealthi
known
previous
vaccin
coronaviru
anim
receiv
singl
inject
ml
intramuscularli
neck
anim
vaccin
group
immunis
prepar
contain
antigen
unit
coronaviru
per
dose
whilst
anim
control
group
vaccin
salineoil
emuls
placebo
contain
none
vaccin
antigen
rectal
temperatur
taken
anim
either
day
vaccin
studi
b
immedi
vaccin
studi
c
approxim
h
vaccin
day
vaccin
site
inject
site
examin
local
reaction
day
day
day
vaccin
calv
beef
suckler
herd
studi
b
allow
unrestrict
access
dam
suckl
calv
dairi
herd
studi
c
fed
twice
day
hand
approxim
l
colostrum
milk
mother
least
day
life
blood
sampl
collect
cow
interv
prevaccin
postcalv
indic
result
section
studi
b
milk
sampl
dam
blood
sampl
calf
collect
day
interv
day
calv
postsuckl
day
postcalv
whilst
studi
c
sampl
taken
day
calv
postsuckl
three
day
postcalv
blood
sampl
process
describ
colostrum
milk
sampl
store
prior
test
presenc
bcov
neutralis
antibodi
prior
test
sera
thaw
heattreat
min
subaliquot
store
frozen
requir
colostrum
milk
sampl
thaw
centrifug
g
min
heavi
liquid
fraction
remov
asept
pipett
clean
steril
contain
steril
rennet
solut
ad
concentr
vv
incub
h
mixtur
centrifug
g
min
upper
liquid
fraction
whey
asept
remov
pipett
dispens
subaliquot
least
ml
storag
bovin
coronaviru
neutralis
antibodi
respons
use
standard
plaqu
reduct
assay
viral
plaqu
visualis
haemadsorpt
use
wv
rat
red
blood
cell
viru
neutralis
vn
titr
end
point
follow
challeng
plaqu
form
unit
bcov
bovin
coronaviru
haemagglutin
inhibit
hai
antibodi
follow
test
sera
pretreat
remov
agglutinin
inhibitor
incub
equal
volum
wv
rat
red
blood
cell
overnight
follow
treatment
wv
potassium
period
min
room
temperatur
standard
hai
methodolog
use
doubl
dilut
ml
sampl
ml
pb
contain
bovin
serum
albumin
test
sampl
carri
v
bottom
microwel
plate
equal
volum
bcov
antigen
contain
four
haemagglutin
unit
ad
incub
h
room
temperatur
ml
wv
rat
red
blood
cell
ad
test
plate
incub
overnight
haemagglutin
antibodi
titr
reciproc
highest
dilut
give
inhibit
agglutin
allow
pretreat
dilut
anim
possess
preexist
antibodi
bovin
coronaviru
measur
hai
rang
log
vn
rang
log
increas
antibodi
titr
could
detect
either
hai
vn
anim
immunis
lowest
dose
bcov
antigen
unit
howev
anim
receiv
antigen
unit
bcov
antigen
show
increas
mean
hai
antibodi
titr
day
peak
hai
titr
log
log
observ
either
day
postvaccin
antigen
unit
per
dose
day
postvaccin
antigen
unit
per
dose
respect
anim
maintain
day
show
steadi
drop
titr
approxim
log
per
month
day
fig
vn
antibodi
respons
similar
peak
earlier
day
titr
approxim
log
howev
vn
antibodi
level
declin
day
cattl
receiv
antigen
unit
fig
obtain
anim
receiv
higher
dose
unit
declin
day
group
immunis
antigen
unit
bcov
still
possess
vn
titr
log
preimmunis
titr
day
postvaccin
fig
sentinel
group
show
increas
antibodi
bcov
either
hai
vn
studi
result
studi
bcov
antigen
load
antigen
unit
per
dose
select
studi
basi
like
produc
optim
antibodi
respons
term
antibodi
titr
durat
vaccin
cowcalf
studi
therefor
formul
level
vaccin
well
toler
local
system
side
eect
observ
antibodi
result
studi
shown
fig
sinc
viru
neutralis
key
paramet
involv
protect
lactogen
immun
antibodi
titr
determin
vn
except
studi
b
serum
vn
antibodi
level
placebo
group
chang
cours
experi
studi
b
howev
placebo
treat
anim
show
increas
serum
vn
antibodi
level
log
experi
suggest
wild
type
bcov
circul
within
herd
immunis
serum
vn
antibodi
level
vaccin
group
show
p
increas
serum
vn
antibodi
level
compar
observ
placebo
control
group
mean
serum
vn
antibodi
level
increas
least
log
day
postvaccin
level
typic
maintain
calv
associ
increas
serum
vn
antibodi
level
day
colostrum
vn
antibodi
also
higher
log
test
vaccin
group
compar
placebo
control
group
similar
dierenc
maintain
milk
antibodi
throughout
period
studi
day
dairi
farm
day
beef
suckler
farm
smallest
increas
occur
studi
b
seroconvers
amongst
placebo
treat
anim
observ
fig
serum
taken
calv
allow
suckl
vaccin
dam
show
level
circul
vn
antibodi
tenfold
higher
obtain
calv
suckl
placebovaccin
cow
eect
interv
vaccin
calv
increas
milk
vn
antibodi
titr
seen
tabl
data
studi
b
combin
set
set
compris
cow
three
vaccin
three
placebo
cow
studi
mean
vaccinationcalv
interv
day
respect
placebo
treat
anim
irrespect
vaccinationcalv
interv
day
colostrum
possess
vn
titr
ap
proxim
log
fall
rapidli
level
approxim
log
background
day
milk
contrast
vaccin
cattl
day
colostrum
possess
vn
titr
approxim
log
much
slower
reduct
antibodi
level
approach
background
level
milk
durat
milk
antibodi
respons
seen
vaccin
anim
vaccinationcalv
interv
day
less
mark
interv
longer
reduc
respons
vaccin
seen
approxim
vaccin
set
bcov
antigen
input
formul
vaccin
measur
elisa
sinc
measur
base
infect
quantit
total
antigen
mass
viabl
viru
particl
therefor
could
use
postinactiv
elisa
procedur
use
primarili
target
toward
viral
haemagglutinin
shown
contain
key
viru
neutralis
epitop
antigen
level
could
therefor
track
throughout
formul
process
result
dose
respons
studi
indic
presenc
preexist
antibodi
rel
larg
amount
immunogen
antigen
unit
need
stimul
increas
bcov
serum
antibodi
titr
appear
minor
dierenc
pattern
antibodi
respons
determin
either
hai
vn
hai
respons
peak
later
vn
respons
may
dierenc
antibodi
aniti
subclass
requir
two
method
antibodi
measur
term
neutralis
antibodi
major
eect
increas
antigen
content
appear
durat
rather
magnitud
respons
vaccin
dose
contain
antigen
unit
antigen
respons
rapid
reach
plateau
approxim
day
postvaccin
maintain
least
day
postvaccin
dose
contain
antigen
unit
antigen
viru
neutralis
respons
equal
rapid
similar
magnitud
although
contrast
declin
rapidli
day
postvaccin
select
correct
antigen
load
therefor
appear
critic
ensur
optim
window
term
interv
vaccin
calv
addit
advantag
use
higher
antigen
dose
also
demonstr
cow
calf
studi
b
elev
antibodi
respons
still
observ
even
face
circul
infect
suggest
vaccin
could
still
play
role
enhanc
overal
herd
immun
even
activ
diseas
situat
fig
mean
bcov
vn
antibodi
result
sera
milk
vaccin
q
placebo
treat
q
cow
sera
respect
calv
studi
carri
four
farm
two
beef
suckler
herd
b
two
dairi
herd
c
sampl
obtain
vaccin
v
calv
c
number
day
indic
event
error
bar
denot
limit
main
sourc
antibodi
bovin
mammari
secret
serum
igg
select
transfer
serum
throughout
lactat
albeit
reduc
level
milk
compar
colostrum
initi
serolog
data
therefor
suggest
bcov
antigen
load
approxim
antigen
unit
success
vaccin
could
take
place
time
week
precalv
hypothesi
support
observ
magnitud
antibodi
titr
found
colostrum
milk
cow
vaccin
dierent
time
precalv
vaccin
contain
antigen
unit
bcov
respons
colostrum
milk
observ
end
vaccin
window
although
cow
vaccin
approxim
day
precalv
appear
show
optim
respons
individu
larg
variat
level
bcov
antibodi
present
vaccin
placebo
control
group
throughout
studi
variabl
particularli
notic
colostrum
milk
sampl
presum
aros
dierenti
level
preexist
bcov
antibodi
observ
anim
although
would
expect
advers
aect
statist
test
result
dierenc
p
b
test
control
group
found
major
day
test
contrast
strongli
previous
report
studi
wherein
increas
bcov
antibodi
titr
serum
milk
follow
vaccin
either
minim
nonexist
reason
improv
respons
observ
test
vaccin
relat
concentr
bcov
antigen
present
use
oil
adjuv
gener
report
highli
eectiv
enhanc
rotaviru
antibodi
titr
mammari
secret
magnitud
antibodi
respons
observ
follow
singl
vaccin
may
result
use
preprim
result
previou
infect
cattl
bovin
coronaviru
ubiquit
situat
extrem
dicult
seroneg
individu
observ
support
data
present
studi
total
heifer
cow
previou
bcov
vaccin
histori
test
prior
treatment
found
substanti
level
preexist
antibodi
major
declin
antibodi
level
present
mammari
secret
observ
day
calv
consist
previous
report
research
show
switch
colostrum
milk
associ
decreas
immunoglobulin
concentr
enhanc
antibodi
level
maintain
day
postcalv
although
bcov
antibodi
level
decreas
calv
becom
suscept
subclin
infect
infect
stimul
activ
immun
henc
confer
long
term
protect
upon
calf
beef
suckler
situat
calf
allow
suckl
natur
dam
rel
easi
ensur
continu
presenc
protect
antibodi
gut
lumen
dairi
situat
typic
calf
allow
access
colostrum
prevent
suckl
milk
thu
fail
ensur
presenc
protect
antibodi
gut
lumen
beyond
day
birth
feed
regimen
therefor
requir
wherebi
colostrum
tabl
eect
interv
vaccin
calv
magnitud
bcov
vn
antibodi
respons
mammari
secret
mean
log
bcov
vn
antibodi
titr
colostrummilk
follow
vaccin
time
calv
feed
continu
part
calv
diet
least
week
life
level
antibodi
present
colostrum
sampl
dairi
herd
studi
c
show
mark
drop
titr
day
associ
switch
colostrum
milk
may
exacerb
dilut
eect
relat
larger
volum
milk
produc
dairi
cattl
compar
beef
cattl
antibodi
level
howev
higher
placebo
treat
group
equival
seen
milk
beef
cattl
day
postcalv
continu
feed
colostrum
pool
collect
obtain
day
postcalv
therefor
provid
enhanc
level
protect
calf
time
period
accept
analog
rotaviru
infect
calf
transmiss
gastroenter
viru
infect
piglet
lactogen
immun
protect
bcov
infect
calf
experiment
crouch
cf
unpublish
observ
howev
problem
assess
ecaci
vaccin
protect
base
boost
lactogen
immun
result
number
variabl
interact
eect
appar
level
protect
obtain
variabl
includ
manag
system
target
anim
titr
antibodi
achiev
colostrum
milk
durat
enhanc
antibodi
respons
volum
time
antibodi
ingest
natur
amount
pathogen
challeng
key
paramet
abl
directli
design
vaccin
titr
durat
antibodi
achiev
colostrum
milk
report
indic
singl
dose
coronaviru
vaccin
administ
pregnant
heifer
week
calv
capabl
increas
titr
durat
antibodi
present
colostrum
milk
work
current
underway
minimum
level
antibodi
requir
protect
calf
challeng
thu
establish
durat
immun
